- Lobbying
- Lisa AND Layman
Lobbying Arrangements Results for 'Lisa Layman'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details H.R. 2212 & S. 974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act. |
Brown Rudnick, LLP, on behalf of Amneal Phramaceuticals
|
Hooper, Lundy & Bookman, P.C. | |||
Details P.L. 111-148 - The Affordable Care Act relating to the CMS innovation awards |
Neuroscience Centers of Florida Foundation, Inc.
|
Brown Rudnick LLP | |||
Details Issues relating to payment for skilled nursing facilities |
Health Care Navigators, LLC
|
Brown Rudnick LLP | |||
Details H.R. 2212 & S. 974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act. |
Brown Rudnick, LLP, on behalf of Lupin Pharmaceuticals, Inc.
|
Hooper, Lundy & Bookman, P.C. | |||
Details Issues relating to New York Medicaid home health reimbursements Issues relating to New York managed care |
Revival Home Health Care
|
Brown Rudnick LLP | |||
Details Issues related to clinical diagnostic laboratory services; S. 2333 Pandemic and All-Hazards Preparedness and Response Act, issues related to public health emergency preparedness; HR 4366-Fiscal Yea... |
Roche Diagnostics Corporation
|
Hooper, Lundy & Bookman, P.C. | |||
Details Issues and policies relating to mental health and substance use disorder parity. H.R. 1628, the American Health Care Act of 2017, provisions related to Medicaid and mental health and substance use.... |
Association for Behavioral Healthcare
|
Brown Rudnick LLP | |||
Details Federal policy relating to pharmaceutical pricing |
Zydus Pharmaceuticals USA Inc.
|
Brown Rudnick LLP | |||
Details HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. HHS-OIG rule RIN-936-AAO8,Removal of Safe Harbor Protections for Rebates to Plans or PBMs Involving Prescription Pharmaceuticals a... |
Brown Rudnick, LLP, on behalf of Prime Therapeutics
|
Hooper, Lundy & Bookman, P.C. | |||
Details Issues related to behavioral health care; Issues related to workforce shortages; Issues related to substance use; Issues related to telehealth flexibilities; H.R. 4531, SUPPORT for Patients and Com... |
Association for Behavioral Healthcare
|
Hooper, Lundy & Bookman, P.C. | |||
Details H.R. 3590 - Patient Protection and Affordability Act relating to PBM transparency H.R. 616 & S. 511 - Relating to pharmacy exemption from Medicare Accreditation requirements H.R. 3590 - Patient Pro... |
National Community Pharmacists Association
|
Brown Rudnick LLP | |||
Details The Blocking Act (H.R. 938); Strengthening Health Care and Lowering Prescription Drug Costs (H.R. 987); Lower Health Care Costs Act (Sec.205) (S. 1895). |
Government Counsel, LLC (obo) Lupin Pharmaceuticals, Inc.
|
Hooper, Lundy & Bookman, P.C. | |||
Details Federal policy relating to pharmaceutical pricing and FDA application review protocols |
Exela Holdings, LLC
|
Brown Rudnick LLP | |||
Details Proposals related to anatomic pathology and the in-office ancillary services exception to the Ethics in Patient Referrals Act. |
Miraca Life Sciences
|
Brown Rudnick LLP | |||
Details H.R. 2049 - Ambulatory Surgical Center Access Act of 2009; Issues relating to ambulatory surgical center payment rates and covered surgical procedures |
Surgical Care Affiliates
|
Brown Rudnick LLP | |||
Details issues relating to the marketing and promotional practices of durable medical equipment supplies |
Quality Diabetes Care Coalition
|
Brown Rudnick LLP | |||
Details Medicare Physician Fee Schedule relating to vascular access procedures and CMS Fistula First Initiative CMMI Coordinated kidney care pilots Proposed rule regarding Medicare shared savings Program: ... |
Village Health
Healthcare |
Brown Rudnick LLP | |||
Details H.R. 4872 /P.L. 111-152 - Health Care and Education Reconciliation Act of 2010, issues related to Medicare delivery of patient centered care H.R. 3590/P.L. 111-148 - Patient Protection and Affordab... |
National Partnership for Women and Families
|
Brown Rudnick LLP | |||
Details Policies to incentivize biosimilars and coding, Medicare Rx Price Negotiation Impact on Biosimilars in Build Back Better Act. Electronic prescription information. Patent thickets and patent reform,... |
Fresenius Kabi, LLC
|
Hooper, Lundy & Bookman, P.C. | |||
Details Paid family leave - House/Senate Family and Medical Leave Act Modernization, including H.R. 5037/S. 2574, the FAIR Leave Act Pregnant Workers Fairness Act Regulations and Guidance - DOL & EEOC P... |
Society for Human Resource Management
|
in-house lobbying | |||
Details H.R. 1671/S. 2771 Increasing Access to Dental Insurance Act; Issues related to operation of the Affordable Care Act exchanges, Issues related to expanding access to dental benefits. H.R. 1385/S. 14... |
National Association of Dental Plans
|
Hooper, Lundy & Bookman, P.C. | |||
Details CMS Proposed Rule {CMS-1631-P} RIN 0938-AS40 - Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2016 S. 1137-Protecting American Talent and Entrep... |
Hospira, Inc.
|
Brown Rudnick LLP | |||
Details Issues relating to community health and hospital industry consolidation |
Norwalk Hospital
Healthcare |
Brown Rudnick LLP | |||
Details H.R. 1038 & S.413-Improving Transparency and Accuracy in Medicare Part D Drug Spending Act (DIR); S.771 & H.R. 1776-Improving Access to Affordable Prescription Drugs Act; H.R.1316-The Prescription ... |
Prime Therapeutics
|
Brown Rudnick LLP | |||
Details H.R. 3271 - Protecting Access to Diabetic Testing Supplies Act of 2017;S. 1914 - Protecting Access to Diabetes Supplies Act of 2017;Yet to be introduced House proposal for a regulatory framework fo... |
Roche Diagnostics Corporation
|
Brown Rudnick LLP | |||
Details Issues relating to oversight of PBM services; S. 2973-Modernizing and Ensuring PBM Accountability Act; S. 3430 - Better Mental Healthcare, Lower Cost Drugs & Extenders Act (provisions related to PB... |
Government Counsel, LLC (obo) Prime Therapeutics
|
Hooper, Lundy & Bookman, P.C. | |||
Details H.R.2212 & S.974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act. H.R. 5311 & S.2456-CARA 2.0 Act of 2018 Bipartisan Budget Act of 2018; Consolidated Appropriations Act ... |
Amneal Pharmaceuticals
|
Brown Rudnick LLP | |||
Details Implementation of Affordable Care Act and related regulations related to the pediatric dental benefit; issues and policies related to ensuring tax incentives for employers and individuals to purcha... |
National Association of Dental Plans
|
Brown Rudnick LLP | |||
Details H.R. 2212 & S. 974, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act; S. 2476-Expanding Access to Low Cost Generic Drugs Act; Issues relating to generic drug pricing; Pub... |
Apotex Corporation
|
Brown Rudnick LLP | |||
Details Public Law 115-271-SUPPORT for Patients and Communities Act; S.469-The Affordable and Safe Prescription Drug Importation Act; Public Law 114-145-The Ensuring Patient Access and Effective Drug Enfor... |
Healthcare Distribution Alliance f/k/a Healthcare Distribution Management Assoc.
|
Brown Rudnick LLP | |||
Details Prescription Drug Costs. H.R.5429/S.2780: Medication Affordability and Patent Integrity Act. 180-Day Exclusivity. S.1114: Expanding Access to Low-Cost Generics Act of 2023. H.R.5461/S.2129: Ensurin... |
Association for Accessible Medicines
|
in-house lobbying |